Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardiovascular RehAbilitation in Patients With Severe AoRtic StEnosis Submitted to Valvar Correction: Effects on Muscle Architecture, Tissue Oxygenation, EndoThelial Function, Inflammatory Profile, and AutoNomic Control - Randomized Trial

NCT02468219 is registered in ClinicalTrials.gov with Irmandade Santa Casa de Misericórdia de Porto Alegre as lead sponsor.

NCT NCT02468219
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02468219 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardiovascular RehAbilitation in Patients With Severe AoRtic StEnosis Submitted to Valvar Correction: Effects on Muscle Architecture, Tissue Oxygenation, EndoThelial Function, Inflammatory Profile, and AutoNomic Control - Randomized Trial
Lead sponsor
Irmandade Santa Casa de Misericórdia de Porto Alegre
Phase
Not applicable
Overall status
Unknown status
Start date
August 31, 2020
Completion date
July 31, 2022
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aortic valve stenosis